A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)
Clinical trial NCT06643481 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06643481
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-17
- Primary completion
- 2026-06-23
- Enrollment
- 251
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.